Allspring Global Investments’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-198
| Closed | -$1.43K | – | 2298 |
|
2024
Q3 | $1.43K | Sell |
198
-48,610
| -100% | -$351K | ﹤0.01% | 2297 |
|
2024
Q2 | $530K | Buy |
48,808
+176
| +0.4% | +$1.91K | ﹤0.01% | 1497 |
|
2024
Q1 | $911K | Sell |
48,632
-6,956
| -13% | -$130K | ﹤0.01% | 1393 |
|
2023
Q4 | $1.2M | Sell |
55,588
-3,205
| -5% | -$69.5K | ﹤0.01% | 1295 |
|
2023
Q3 | $1.21M | Sell |
58,793
-43,850
| -43% | -$902K | ﹤0.01% | 1318 |
|
2023
Q2 | $4.83M | Buy |
102,643
+8,200
| +9% | +$386K | 0.01% | 1013 |
|
2023
Q1 | $3.96M | Buy |
94,443
+6,871
| +8% | +$288K | 0.01% | 1054 |
|
2022
Q4 | $3.34M | Sell |
87,572
-9,961
| -10% | -$380K | 0.01% | 1095 |
|
2022
Q3 | $3.82M | Buy |
97,533
+24,367
| +33% | +$954K | 0.01% | 1049 |
|
2022
Q2 | $2.36M | Sell |
73,166
-1,260
| -2% | -$40.7K | ﹤0.01% | 1175 |
|
2022
Q1 | $2.46M | Sell |
74,426
-1,811
| -2% | -$59.9K | ﹤0.01% | 1401 |
|
2021
Q4 | $3.24M | Buy |
+76,237
| New | +$3.24M | ﹤0.01% | 1328 |
|